A look at current and potential treatment approaches for hormone receptor‐positive, HER2‐negative early breast cancer-Reference-Cited by-同舟云学术

A look at current and potential treatment approaches for hormone receptor‐positive, HER2‐negative early breast cancer

Published:2022-05-10 Issue:S11 Volume:128 Page:2209-2223
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Harbeck Nadia¹,Burstein Harold J.²,Hurvitz Sara A.³⁴,Johnston Stephen⁵,Vidal Gregory A.⁶⁷

Affiliation:

1. Breast Center Department of Obstetrics & Gynecology and CCCMunich LMU University Hospital Munich Germany

2. Dana Farber Cancer Institute Harvard Medical School Boston Massachusetts

3. Breast Cancer Clinical Research Program Division of Hematology/Oncology David Geffen School of Medicine at the University of California Los Angeles (UCLA) Los Angeles California

4. Santa Monica‐UCLA Outpatient Hematology/Oncology Practice Santa Monica California

5. The Institute of Cancer Research The Royal Marsden National Health Service Foundation Trust London United Kingdom

6. Clinical Research Division of Breast Cancer West Cancer Center and Research Institute Memphis Tennessee

7. Department of Hematology/Oncology The University of Tennessee Health Science Center Memphis Tennessee

Funder

Eli Lilly and Company

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cncr.34161

Reference72 articles.

1. Systemic Therapy for Estrogen Receptor–Positive, HER2-Negative Breast Cancer

2. Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

3. Eighth Edition of the AJCC Cancer Staging Manual: Breast Cancer

4. Assessment of Ki67 in Breast Cancer: Updated Recommendations From the International Ki67 in Breast Cancer Working Group

5. Estrogen and Progesterone Receptor Testing in Breast Cancer: ASCO/CAP Guideline Update

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The treatment pattern of advanced HR-positive and HER2-negative breast cancer in central southern China: a hospital-based cross-sectional study;BMC Cancer;2024-07-30

2. Evaluation of novel synthesized thiazole derivatives as potential aromatase inhibitors against breast cancer;Future Medicinal Chemistry;2024-03-15

3. Adjuvant Chemotherapy in Premenopausal Patients With Hormone-Positive Breast Cancer With a Recurrence Score of 16-25: A Retrospective Analysis Using the National Cancer Database;JCO Precision Oncology;2024-03

4. Association between NDRG1 protein expression and aggressive features of breast cancer: a systematic review and meta-analysis;BMC Cancer;2023-10-19

5. Traitements systémiques ciblés et radiothérapie locorégionale pour les cancers du sein : peut-on espérer un bénéfice de la potentialisation du traitement local ?;Cancer/Radiothérapie;2023-09